As of 1:24pm ET
| +0.16 / +2.04%|
The 7 analysts offering 12-month price forecasts for Cardiome Pharma Corp have a median target of 13.00, with a high estimate of 16.00 and a low estimate of 9.00. The median estimate represents a +62.50% increase from the last price of 8.00.
The current consensus among 7 polled investment analysts is to Buy stock in Cardiome Pharma Corp. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.